NIH-PA Author Manuscript

NIH-PA Author Manuscript

NIH-PA Author Manuscript35. Catania A, Lipton JM. alpha-Melanocyte stimulating hormone in the modulation of host reactions.Endocr Rev 1993;14:564–576. [PubMed: 8262006]36. Hiltz ME, Lipton JM. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptidealpha-MSH. Faseb J 1989;3:2282–2284. [PubMed: 2550304]37. Hiltz ME, Catania A, Lipton JM. Alpha-MSH peptides inhibit acute inflammation induced in miceby rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF andrIL-8. Cytokine 1992;4:320–328. [PubMed: 1325196]38. Getting SJ, Gibbs L, Clark AJ, et al. POMC gene-derived peptides activate melanocortin type 3receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acuteexperimental inflammation. J Immunol 1999;162:7446–7453. [PubMed: 10358199]39. Delgado R, Carlin A, Airaghi L, et al. Melanocortin peptides inhibit production of proinflammatorycytokines and nitric oxide by activated microglia. J Leukoc Biol 1998;63:740–745. [PubMed:9620667]40. Adachi S, Nakano T, Vliagoftis H, et al. Receptor-mediated modulation of murine mast cell functionby alpha-melanocyte stimulating hormone. J Immunol 1999;163:3363–3368. [PubMed: 10477606]41. Haycock JW, Rowe SJ, Cartledge S, et al. Alpha-melanocyte-stimulating hormone reduces impactof proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanomacell lines. J Biol Chem 2000;275:15629–15636. [PubMed: 10821844]42. Chen W, Kelly MA, Opitz-Araya X, et al. Exocrine gland dysfunction in MC5-R-deficient mice:evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell1997;91:789–798. [PubMed: 9413988]43. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactionsbetween nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 1999;20:435–459. [PubMed: 10453354]44. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone andfludrocortisone on mortality in patients with septic shock. Jama 2002;288:862–871. [PubMed:12186604]45. van der Poll T, Marchant A, Buurman WA, et al. Endogenous IL-10 protects mice from death duringseptic peritonitis. J Immunol 1995;155:5397–5401. [PubMed: 7594556]

46. Song GY, Chung CS, Chaudry IH, et al. What is the role of interleukin 10 in polymicrobial sepsis:

anti-inflammatory agent or immunosuppressant? Surgery 1999;126:378–383. [PubMed: 10455909]

47. Bhardwaj RS, Schwarz A, Becher E, et al. Pro-opiomelanocortin-derived peptides induce IL-10

production in human monocytes. J Immunol 1996;156:2517–2521. [PubMed: 8786313]

48. Yamaoka-Tojo M, Tojo T, Shioi T, et al. Central neurotranspeptide, alpha-melanocyte-stimulating

hormone (alpha-MSH) is upregulated in patients with congestive heart failure. Intern Med

2006;45:429–434. [PubMed: 16679696]

49. Vulliemoz NR, Xiao E, Xia-Zhang L, et al. Melanocortin modulation of inflammatory cytokine and

neuroendocrine responses to endotoxin in the monkey. Endocrinology 2006;147:1878–1883.

[PubMed: 16410297]

50. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock,

and multiple organ dysfunction. Crit Care Med 1999;27:1230–1251. [PubMed: 10446814]

51. Oberholzer C, Tschoeke SK, Moldawer LL, et al. Local thymic caspase-9 inhibition improves survival

during polymicrobial sepsis in mice. J Mol Med 2006;84:389–395. [PubMed: 16453149]

52. Weaver JG, Rouse MS, Steckelberg JM, et al. Improved survival in experimental sepsis with an orally

administered inhibitor of apoptosis. Faseb J 2004;18:1185–1191. [PubMed: 15284218]

53. Wesche-Soldato DE, Chung CS, Lomas-Neira J, et al. In vivo delivery of caspase-8 or Fas siRNA

improves the survival of septic mice. Blood 2005;106:2295–2301. [PubMed: 15941915]

54. Bohm M, Wolff I, Scholzen TE, et al. alpha-Melanocyte-stimulating hormone protects from

ultraviolet radiation-induced apoptosis and DNA damage. J Biol Chem 2005;280:5795–5802.

[PubMed: 15569680]

55. Kadekaro AL, Kavanagh R, Kanto H, et al. alpha-Melanocortin and endothelin-1 activate

antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 2005;65:4292–4299. [PubMed: 15899821]